The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Mar. 03, 2020
Filed:
Sep. 21, 2017
Applicants:
Biotie Therapies Corp., Turku, FI;
The University of Birmingham, Birmingham, GB;
Inventors:
Christopher Weston, Stourbridge, GB;
Lee Charles Claridge, Kingswinford, GB;
David Adams, Birmingham, GB;
David Smith, Naantali, FI;
Nina Westerlund, Turku, FI;
Marjo Pihlavisto, Kaarina, FI;
Thua Österman, Turku, FI;
Assignees:
BIOTIE THERAPIES CORP., Turku, FI;
THE UNIVERSITY OF BIRMINGHAM, Birmingham, GB;
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 39/395 (2006.01); A61K 31/00 (2006.01); C07K 16/40 (2006.01); A61K 31/137 (2006.01); A61K 31/185 (2006.01); A61K 39/00 (2006.01); G01N 33/68 (2006.01); G01N 33/573 (2006.01);
U.S. Cl.
CPC ...
A61K 39/3955 (2013.01); A61K 31/00 (2013.01); A61K 31/137 (2013.01); A61K 31/185 (2013.01); C07K 16/40 (2013.01); G01N 33/573 (2013.01); G01N 33/6893 (2013.01); A61K 2039/505 (2013.01); C07K 2317/76 (2013.01); G01N 2333/90638 (2013.01); G01N 2800/085 (2013.01);
Abstract
The present invention relates to inhibitors of VAP-1 and their use as medicaments in treating fibrotic conditions. Furthermore, the present invention relates to a method of diagnosing a fibrotic condition on the basis of elevated level of soluble VAP-1 or SSAO activity in a bodily fluid, and to a kit for use in said diagnostic method.